Key result
Combined CABG and restrictive annuloplasty in patients with ischemic mitral regurgitation significantly reduced LV end-systolic dimension from 51 to 43 mm (P<0.001) at 2 years.
Why the study?
Does combined CABG and restrictive annuloplasty improve left ventricular reverse remodeling and clinical outcomes in patients with ischemic cardiomyopathy and severe mitral regurgitation?
Population
51 patients with ischemic LV dysfunction and severe mitral regurgitation
Design
Cohort
Follow-up
2 years
Authors
Loading...
Supports LV reverse remodeling with combined CABG-annuloplasty in ischemic MR; hypothesis-generating and should not yet change practice pending RCTs.
Observational (n=51)
Does combined CABG and restrictive annuloplasty improve left ventricular reverse remodeling and clinical outcomes in patients with ischemic cardiomyopathy and severe mitral regurgitation?
p-value: p=<0.001
Combined restrictive annuloplasty and CABG in patients with ischemic cardiomyopathy and severe mitral regurgitation leads to significant left ventricular reverse remodeling and symptomatic improvement at 2 years.
Bax et al. (2004) conducted an observational in Ischemic cardiomyopathy with severe mitral regurgitation (n=51). CABG and restrictive annuloplasty was evaluated on LV end-systolic dimension (mm) (p=<0.001). Combined CABG and restrictive annuloplasty in patients with ischemic mitral regurgitation significantly reduced LV end-systolic dimension from 51 to 43 mm (P<0.001) at 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: